| Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment NA Valdez-Cruz, E García-Hernández, C Espitia, L Cobos-Marín, ... Microbial cell factories 20 (1), 88, 2021 | 58 | 2021 |
| Energetic and structural effects of the Tanford transition on ligand recognition of bovine β-lactoglobulin A Labra-Núñez, LF Cofas-Vargas, G Gutiérrez-Magdaleno, ... Archives of Biochemistry and Biophysics 699, 108750, 2021 | 10 | 2021 |
| Computational Design of Inhibitors Targeting the Catalytic β Subunit of Escherichia coli FOF1-ATP Synthase LP Avila-Barrientos, LF Cofas-Vargas, G Agüero-Chapin, ... Antibiotics 11 (5), 2022 | 3 | 2022 |
| The GōMartini approach: Revisiting the concept of contact maps and the modelling of protein complexes LF Cofas-Vargas, RA Moreira, S Poblete, M Chwastyk, AB Poma Acta Physica Polonica A, 2024 | 2 | 2024 |
| Exploring the druggability of the binding site of aurovertin, an exogenous allosteric inhibitor of FOF1-ATP synthase LF Cofas-Vargas, P Mendoza-Espinosa, LP Avila-Barrientos, ... Frontiers in Pharmacology 13, 1012008, 2022 | 2 | 2022 |
| Beta-KTx14. 3, a scorpion toxin, blocks the human potassium channel KCNQ1 G Titaux-Delgado, AE Lopez-Giraldo, E Carrillo, LF Cofas-Vargas, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1871 (4), 140906, 2023 | 1 | 2023 |
| Capturing the biomechanics of SARS-COV-2/antibody complexes by GōMartini simulation LF Cofas-Vargas, A Poma Biophysical Journal 123 (3), 44a, 2024 | | 2024 |
| GōMartini 3: From large conformational changes in proteins to environmental bias corrections PCT Souza, LP Borges Araujo, C Brasnett, RA Moreira, F Grunewald, ... bioRxiv, 2024.04. 15.589479, 2024 | | 2024 |
Enrique Garcia-HernandezInstituto de Quimica, UNAMVerified email at unam.mx
